Our portfolio of products contains new innovative crop-derived Health Ingredients from sustainable sources.
All our ingredients undergo clinical trials to demonstrate their efficacy in improving human health and are fully protected by a broad intellectual property portfolio of patents.
Our most advanced product, Xtramune™ (NL-01) is a unique proprietary carrot-derived fibre under development to support immune function and improve resistance to respiratory infections.
Xtramune™ is being developed as a natural food ingredient. We have obtained proof of concept in humans and the ingredient is currently in a clinical efficacy trial involving a challenge with a common cold virus, while a third trial in subjects with increased susceptibility to respiratory tract infections is scheduled to start second half 2018.
Xtramune™ is expected to be ready for formulation in dietary supplements in 2019, followed by medical food and functional foods later on.
NL-02 is an innovative crop-derived food ingredient under development to improve gut health of consumers and patients. NL-02 is in pre-clinical stage.
NL-03 is our third lead, under development to improve metabolic health through gut microbiome modulation and is currently in the discovery stage.